In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
The American Association for Cancer Research (AACR) publishes eight esteemed scientific journals. Each month, these journals feature a wide...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of types of cancer for which pembrolizumab...
Lymphomas are a collection of blood cancers stemming from aberrant lymphocytes, which are critical components of the immune system....
For many aspiring investigators, pursuing a career in cancer research can be a complex exploration of self and purpose. In...
This week, President Trump signed the Childhood Cancer Survivorship, Treatment, Access and Research (STAR) Act, which is aimed at...
“We are in a promising time for cancer research and treatment; however, ovarian cancer remains difficult to treat, since...
For cancer patients at the ends of their lives, hospice care can provide access to comfort measures and extra...
The American Association for Cancer Research (AACR) is proud to support the Scientist↔Survivor Program (SSP), which provides cancer survivors...
Assessing new anticancer therapeutics in clinical trials is a vital step in evaluating the toxicity and efficacy of treatment...
Skin cancer is the most commonly diagnosed cancer in the United States. Every year, about 5 million Americans are...